FRISCO, Texas, Feb. 28, 2024 /PRNewswire/ — Baird Medical Devices, Inc. (“Baird Medical” or the “Company”), a leading microwave ablation (“MWA”) medical device developer and provider in China and the United States, today announced that it is accelerating its expansion in the United…
Month: February 2024
FRISCO, Texas, Feb. 28, 2024 /PRNewswire/ — Baird Medical Devices, Inc. (“Baird Medical” or the “Company”), a leading microwave ablation (“MWA”) medical device developer and provider in China and the United States, today announced that it is accelerating its expansion in the United…
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The ‘Europe Disposable Gloves Market – Industry Outlook & Forecast 2024-2029’ report has been added to ResearchAndMarkets.com’s offering. The European disposable gloves market is expected to grow at a CAGR of 7.71% from 2023 to 2029, reaching a…
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The ‘Europe Disposable Gloves Market – Industry Outlook & Forecast 2024-2029’ report has been added to ResearchAndMarkets.com’s offering. The European disposable gloves market is expected to grow at a CAGR of 7.71% from 2023 to 2029, reaching a…
NEW YORK, Feb. 28, 2024 /PRNewswire/ — The metal additive manufacturing market is expected to grow by USD 7.57 billion from 2022 to 2027. In addition, the growth momentum of the market will progress at a CAGR of 20.84% during the forecast period, according to Technavio. Increased…
70 % der seltenen genetischen Erkrankungen beginnen im Kindesalter (1,2). CASTRES, Frankreich, 28. Februar 2024 /PRNewswire/ — Am 29. Februar findet der Internationale Tag der Seltenen Erkrankungen, der Rare Disease Day®, statt. Aus diesem Anlass bekräftigen die Laboratoires Pierre Fabre…
-Milestone Opportunity Brings Access to Customers via Global Sales and Partner Network VANCOUVER, BC, Feb. 28, 2024 /PRNewswire/ – UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce that it has…
HONG KONG, Feb. 28, 2024 /PRNewswire/ — Akeso (9926.HK) announced that the results of a phase II clinical trial for PD-1/CTLA-4 bispecific antibody（cadonilimab）combined with standard treatment (chemotherapy +/- bevacizumab) as first-line treatment for recurrent/metastatic cervical cancer…
AMSTERDAM, 28 februari 2024 /PRNewswire/ — Group-IB, een toonaangevende ontwikkelaar van cyberbeveiligingstechnologieën voor het onderzoeken, voorkomen en bestrijden van digitale misdaad, heeft met de publicatie van zijn jaarlijkse Hi-Tech Crime Trends-rapport een uitgebreid overzicht…
BARCELONA, Spain, Feb. 28, 2024 /PRNewswire/ — During MWC Barcelona 2024, Huawei held the Huawei Talent Summit and made announcements relevant to several talent development initiatives, including: the launch of the applications for the global ITU-Huawei Generation Connect Young…
